Moore's Compounding Pharmacy Levothyroxine Capsules Recall: Potency Failures
Moore's Compounding Pharmacy recalls 90-count levothyroxine capsules due to potency failures. These capsules may not contain the correct medication dose, risking treatment effectiveness.
Lower-risk recall
Superpotent Drug and Subpotent Drug; potency failures obtained
Contact the company
What happened, in plain English
Moore's Compounding Pharmacy is recalling 90-count levothyroxine sodium capsules that may have potency failures. This means the medication might not contain the correct dose, potentially affecting thyroid treatment effectiveness. Read more at govinfonow.com/recall/42446-moore-s-compounding-pharmacy-levothyroxine-capsules-recall-potency-failures.
Source Summary by GovInfoNow · govinfonow.com/recall/42446-moore-s-compounding-pharmacy-levothyroxine-capsules-recall-potency-failures · Updated October 9, 2026 · FDA enforcement record: FDA #D-0488-2017
Cite this page
“Moore's Compounding Pharmacy Levothyroxine Capsules Recall: Potency Failures.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42446-moore-s-compounding-pharmacy-levothyroxine-capsules-recall-potency-failures. Based on FDA recall #D-0488-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0488-2017%22&limit=1).
Why it’s dangerous
The capsules may have potency failures, meaning they don't contain the correct amount of medication. This could lead to improper thyroid hormone levels if taken as directed. The risk is to treatment effectiveness rather than immediate harm.
Who’s affected
People prescribed levothyroxine who received these capsules from Moore's Compounding Pharmacy in Corpus Christi, TX. Those with thyroid conditions are most at risk of treatment issues.
How to tell if you have this one
Check for 90-count bottles labeled 'Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules' from Moore's Pharmacy Compounding in Corpus Christi, TX. These were sold starting August 22, 2016, and expire February 18, 2017.
- Brand
Moore's Compounding Pharmacy- Category
Drug
What to do — step by step
Check Medication Label
Look for the specific product name and expiration date on the capsule bottle.
Where it went and when
Where it was distributed
Distributed in Texas.
FDA distribution: “TX” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Texas.
Recall timeline
FDA terminated this recall 8 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Are there any safety risks from taking these capsules?
The recall indicates potential treatment effectiveness issues, not immediate safety risks like injury or death.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0488-2017 (September 12, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0488-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.